[3-(2,2-dioxo-1,3-dihydro-2,1-benzothiazol-5-yl)-8-morpholin-4-ylimidazo[1,2-a]pyrazin-2-yl]-phenylmethanone
C24H21N5O4S — CID 122656216
Data last refreshed: (MolForge compound catalog, from PubChem)
About [3-(2,2-dioxo-1,3-dihydro-2,1-benzothiazol-5-yl)-8-morpholin-4-ylimidazo[1,2-a]pyrazin-2-yl]-phenylmethanone
[3-(2,2-dioxo-1,3-dihydro-2,1-benzothiazol-5-yl)-8-morpholin-4-ylimidazo[1,2-a]pyrazin-2-yl]-phenylmethanone (PubChem CID 122656216) has the molecular formula C24H21N5O4S and a molecular weight of 475.53 g/mol. Its IUPAC name is [3-(2,2-dioxo-1,3-dihydro-2,1-benzothiazol-5-yl)-8-morpholin-4-ylimidazo[1,2-a]pyrazin-2-yl]-phenylmethanone.
Molecular Properties
| Compound Name | [3-(2,2-dioxo-1,3-dihydro-2,1-benzothiazol-5-yl)-8-morpholin-4-ylimidazo[1,2-a]pyrazin-2-yl]-phenylmethanone |
|---|---|
| PubChem CID | 122656216 |
| Molecular Formula | C24H21N5O4S |
| Molecular Weight | 475.53 g/mol |
| Exact Mass | 475.13 |
| IUPAC Name | [3-(2,2-dioxo-1,3-dihydro-2,1-benzothiazol-5-yl)-8-morpholin-4-ylimidazo[1,2-a]pyrazin-2-yl]-phenylmethanone |
| SMILES | O=C(c1ccccc1)c1nc2c(N3CCOCC3)nccn2c1-c1ccc2c(c1)CS(=O)(=O)N2 |
| InChI | InChI=1S/C24H21N5O4S/c30-22(16-4-2-1-3-5-16)20-21(17-6-7-19-18(14-17)15-34(31,32)27-19)29-9-8-25-23(24(29)26-20)28-10-12-33-13-11-28/h1-9,14,27H,10-13,15H2 |
| InChIKey | DQTZXUNAMPJHOB-UHFFFAOYSA-N |
| XLogP | 2.72 |
| TPSA | 105.90 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 475.53 |
| LogP ≤ 5 | 2.72 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 122656216 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.